Smallpox vaccine adds to potential biodefense stockpile

Published on December 2, 2009 by Nick Rees

Bavarian Nordic A/S, focusing on biodefense, has announced that it expects to file a new drug submission for Imvamune, its third-generation smallpox vaccine. Read More

Major smallpox vaccine order announcement expected

Published on November 27, 2009 by Paul Tinder

The biodefense company SIGA Technologies, which engages in the discovery, development and commercialization of products for use in defense against biological warfare agents, is expected to make a major announcement. Read More

Nanotherapeutics receives contract to develop smallpox drug

Published on November 2, 2009 by Mary J. Lewis

ALACHUA, Fla. Read More

  Next Entries »